Tevogen Bio Holdings Inc. — Key Metrics
2 years of history · ending 2024-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-5
Book Value Per Share
$-2
Free Cash Flow Per Share
$-4
Cash Per Share
$0
Revenue Per Share
$-0
OCF Per Share
$-4
Return on Equity
27.2%
Return on Assets
-306.2%
Return on Invested Capital
83.7%
Current Ratio
0.26
Quick Ratio
0.26
Asset Turnover
-0.04
R&D / Revenue
-16862.5%
SBC / Revenue
-22150.0%
Capex / Revenue
—
Working Capital
$-7M
Net Current Asset Value
$-8M
Invested Capital
$-7M
OCF / Net Income
0.87
FCF / Net Income
0.87
Accruals Ratio (Sloan)
-49.9%
Net Debt
$0
Net Debt / EBITDA
0.00
Interest Coverage
-291.05
Cash Coverage
-65.20
Capex Coverage
-61.44
Tangible Common Equity
$-7M
TCE / Total Assets
-192.8%
NOPAT
$-42M
Cash ROIC
23.7%
WC / Revenue
3630.7%
Capex / D&A
0.81
Reinvestment Rate
0.3%
Total Payout Ratio
-567.1%
Asset Growth vs Revenue Growth
—
Stock Price (FY-end)
$52
Market Cap
$151M
P/S Ratio
-820.88
Enterprise Value
$151M
EV / Sales
-820.88
FCF Yield
-7.9%
Shareholder Yield
-27.0%
Buyback Yield
2.5%
R&D Yield
20.5%
Capex Yield
0.0%
Shares Variation (YoY)
-88.1%
Beta (5Y)
0.19
Cost of Equity
5.4%
52W High
$567
52W Low
$13
Trailing Return 1Y
-90.7%
F-Score (Piotroski)
4.00
Z-Score (Altman)
-90.35
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.